Answers are grounded in this paper and cite their sources.
This review analyzes antiviral agents' development in viral infections, suggesting new chemotherapy strategies.
Viral infections occupy a leading place in various human pathologies and are one of the main causes of death among people, both in developed and developing countries with a weak health care system. The huge diversity of viruses and their unique variability pose a serious challenge to the developers of antiviral agents. The purpose of this review is to analyze the current state of development of emergency prevention and treatment agents, as well as promising areas for the development of chemotherapy for viral infections. The main direction in the development of effective means for the treatment of viral infections is the creation of medications based on abnormal nucleosides and their precursors, small interfering RNA, releaseactive compounds, and the search for targets among viral proteins. The review considers the most significant results in the field of creating agents for the treatment of viral infections.
No takes yet. Share an insight, caveat, or question.
Loginova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: